About company
ElyssaMed® is a spin-off of Gustave Roussy Institute and develops an active immunotherapy against lung cancer NSCL.
- FR
- contact@elyssamed.com
- Unknown
- elyssamed.com
- Not verified company
ElyssaMed® is a spin-off of Gustave Roussy Institute and develops an active immunotherapy against lung cancer NSCL.